Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3

International Urology and Nephrology

Volumn 46, Issue 8, 2014, Pages 1609-1617

  Wang, Cheng Jun ^a   Bao, Xiao Rong ^a   Du, Guo Wei ^a   Wang, Yu ^a   Chen, Kai ^a   Shen, Ma Li ^a   Wang, Li Zhen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Insulin resistance; Left ventricular hypertrophy

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PARATHYROID HORMONE; UREA; CALCIUM; GLUCOSE BLOOD LEVEL; PHOSPHATE; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MODEL; PARATHYROID HORMONE BLOOD LEVEL; PROGNOSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; COMPLICATION; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD UREA NITROGEN; C-REACTIVE PROTEIN; CALCIUM; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HOMEOSTASIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 84906935745     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0720-3     Document Type: Article

References (44)

1. Kasiske BL, Chavers B, Foley R et al (2002) National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl. 1):S1-S266
2. Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351:1344-1346
3. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038-2047 (Pubitemid 350074801)
4. Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108(17):2154-2169 (Pubitemid 37337595)
5. Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079-1084 (Pubitemid 32378350)
6. Shinohara K, Shoji T, Emoto M et al (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900 (Pubitemid 34700615)
7. Becker B, Kronenberg F, Kielstein JT et al (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16:1091-1098 (Pubitemid 41710320)
8. Rao M, Li L, Tighiouart H et al (2008) Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 23:2619-2628
9. Zoccali C, Mallamaci F, Tripepi G et al (2002) Adiponectin, metabolic risk factors and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141 (Pubitemid 34042020)
10. Ye R, Li Y et al (2007) Clinical nephrology [M]. People's Health Publishing House, Beijing, pp 598-599
11. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419 (Pubitemid 15018832)
12. Yin J, Ming Li L et al (2013) Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr 5:71
13. Devereux RB, Casale PN, Kligfield P et al (1986) Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 57:1388-1393 (Pubitemid 16055293)
14. Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458 (Pubitemid 16119719)
15. Nitta K, Iimuro S, Imai E et al (2013) Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol 17(5):730-742
16. Pietrzak-Nowacka M, Safranow K, Czechowska M et al (2012) Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner. Kidney Blood Press Res 36(1):301-309
17. Lebovitz HE (2001) Review Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109(Suppl. 2): S135-S148
18. Fliser D, Pacini G, Engeleiter R et al (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53:1343-1347 (Pubitemid 28316896)
19. Stefanovic V, Nesic V, Stojimirovic B (2003) Treatment of insulin resistance in uremia. Int J Artif Organs 26(2):100-104 (Pubitemid 36896256)
20. Liao MT, Sung CC, Hung KC et al (2012) Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012: 691369
21. Wang CJ, Bao XR (2009) The relationship between insulin resistance and left ventricular hypertrophy in patients with early chronic kidney disease. Zhonghua Nei Ke Za Zhi 48(12):999-1003
22. Lumiaho A, Pihlajamäki J, Hartikainen J et al (2003) Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am J Kidney Dis 41(6):1219-1224 (Pubitemid 36637977)
23. Kato Y, Hayashi M, Ohno Y et al (2000) Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol 54(5):366-373
24. Kobayashi S, Maseaato K, Moriya H et al (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45:275-280 (Pubitemid 40431052)
25. Balakrishnan VS, Rao M et al (2010) Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin J Am Soc Nephrol 5(6):996-1002
26. Bailey J (2013) Insulin resistance andmusclemetabolismin chronic kidney disease [M]. ISRN Endocrinol 2013(329606):2090-4630
27. Slee AD (2012) Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond) 9:36
28. Stump C (2011) Physical activity in the prevention of chronic kidney disease. Cardiorenal Med 1(3):164-173
29. Rowe JW, Young JB, Minaker KL et al (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30(3):219-225 (Pubitemid 11026317)
30. Esler M, Rumantir M, Kaye D et al (2001) The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens 14:139S-146S (Pubitemid 32506708)
31. Ter Maaten JC, Voorburg A, Heine RJ et al (1997) Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 92(1):51-58 (Pubitemid 27033010)
32. Ferrannini E, Natali A (1993) Insulin resistance and hypertension: connections with sodium metabolism. Am J Kidney Dis 21(Suppl.):37-42 (Pubitemid 23158795)
33. Vierhapper H (1985) Effect of exogenous insulin on blood pressure regulation in healthy and diabetic subjects. Hypertension 7(Suppl. II):1149-1153
34. Sowers JR, Frohlich ED (2004) Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin N Am 88:63-82 (Pubitemid 38165387)
35. Tarkun I, Arslan BC, Cantürk Z et al (2004) Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 89:5592-5596 (Pubitemid 39518445)
36. Muniyappa R, Montagnani M, Koh KK et al (2007) Cardiovascular actions of insulin. Endocr Rev 28(5):463-491 (Pubitemid 47236334)
37. Purohit P, Mathur R (2013) Hypertension association with serum lipoproteins, insulin, insulin resistance and C-peptide: unexplored forte of cardiovascular risk in hypothyroidism. N Am J Med Sci 5(3):195-201
38. Menon V, Rudym D, Chandra P et al (2011) Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol 6:7-13
39. Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391-398 (Pubitemid 351186278)
40. BarazzoniR,GortanCappellariG, ZanettiMet al (2012)Ghrelin and muscle metabolism in chronic uremia. J Ren Nutr 22(1):171-175
41. Kizler TA (2008) Nutrition, inflammation and chronic kidney disease. Curr Opin Nephrol Hypertens 17(2):162-167
42. Mak RHK, DeFronzo RA (1992) Glucose and insulin metabolism in uremia. Nephron 61(4):377-382
43. Chmielewski M, Verduijn M, Drechsler C et al (2011) Low cholesterol in dialysis patients-causal factor for mortality or an effect of confounding? Nephrol Dial Transplant. doi:10.1093/ndt/gfr008
44. Chonchol M, Scragg R (2007) 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71(2):134-139 (Pubitemid 46094686)